GTBIF Research | Milton Maxwell

GTBIF

Green Thumb Industries Inc.

9.63

+1.23+14.7%

Dec 16, 4:00:00 PM EST

Upcoming Earnings

Report date

-/-

Earnings Call Transcripts

This Quarter (Q1 '26)

No earnings call transcript available yet

Last Quarter (Q4 '25)

No earnings call transcript available

Key Stats

Market Cap

2.23B

P/E (TTM)

56.65

Basic EPS (TTM)

0.17

Dividend Yield

Recent Filings

10-K

FY2025 results

2/25/26Feb 25, 2026

No financial statements, results, or quarterly metrics disclosed in the provided 10-K filing. Core data absent.

8-K

Q4 revenue up 5.7%

2/25/26Feb 25, 2026

Green Thumb Industries reported Q4 revenue of $311.1 million, up 5.7% year-over-year, driven by Minnesota adult-use launch despite price compression; full-year revenue hit $1.2 billion. Cash swelled to $274.3 million, with $90 million Q4 operating cash flow and $348.4 million normalized EBITDA. Balance sheet strengthened. Q1 2026 revenues to dip mid-single digits.

8-K

GTI draws $50M term loans

2/20/26Feb 20, 2026

Green Thumb's subsidiary GTI23 drew $50 million in additional term loans on February 19, 2026, via Amendment No. 1 to its September 2024 credit agreement with Valley National Bank. Terms match existing loans; proceeds cover amendment costs while funding strategic investments and working capital. Liquidity boosted. No covenants breached.

10-Q

Q3 FY2025 results

11/5/25Nov 5, 2025

Green Thumb's Q3 revenues edged up 2% y/y to $291.4M while gross margins slipped to 49% from 51% on price compression, yet operating income held at $36.7M despite 2% higher SG&A. Q3 diluted EPS doubled to $0.10 on $23.3M net income, fueled by $41.6M gain on IP divestiture to RYTHM; YTD EPS fell to $0.13 from $0.26 as operating income dropped 29% y/y to $118.7M (derived). Cash swelled to $226.2M with $204.8M YTD operating cash flow, funding $24.4M retail acquisitions in Connecticut (June 2025, $14.2M cash, $5.8M goodwill, $6.0M licenses over 15 years) and $24.8M share repurchases; total debt $247.4M in covenant compliance. Adult-use ramps in Minnesota and Ohio offset competition. Cannabis stays federally illegal.

8-K

Q3 revenue up 1.6%

11/5/25Nov 5, 2025

Green Thumb Industries posted Q3 revenue of $291.4 million, up 1.6% year-over-year despite price compression, with Adjusted EBITDA at $80.2 million or 27.5% margin. Cash flow from operations hit $74.1 million; cash swelled to $226.2 million. Board authorized $50 million share repurchases through September 2026. All eight Minnesota RISE Dispensaries now sell adult-use. Q4 revenue flat to up single digits.

About

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products directly to consumers through its retail stores, as well as direct-to-consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

CEO

Mr. Benjamin Kovler

IPO

6/14/2018

Website

https://www.gtigrows.com

Employees

4,800

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic